Skip to Main Content
CKG
Home
Home
Home
TKG
Author details
Breadcrumb
Author Details
Full Name
William F Hartsell
Affiliation
Proton Therapy Center- Northwestern University
ORCID
Career Start Year
1989
Papers
104
H Index
28
Expertise
CM4AI Collaborator
Sarah J Ratcliffe (CM4AI)
PMID
Paper Title
Journal Title
Published Year
36813169
Clinical outcomes and toxicities of 100 patients treated with proton therapy for chordoma on the proton collaborative group prospective registry.
Radiother Oncol
2023
37498475
Correction to: Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
J Neurooncol
2023
36951945
Radiotherapy for Atypical Teratoid/Rhabdoid Tumor (ATRT) on the Pediatric Proton/Photon Consortium Registry (PPCR).
J Neurooncol
2023
36946610
Proton therapy for high-risk prostate cancer: Results from the Proton Collaborative Group PCG 001-09 prospective registry trial.
Prostate
2023
34808253
Variation in Proton Craniospinal Irradiation Practice Patterns in the United States: A Pediatric Proton Consortium Registry (PPCR) Study.
Int J Radiat Oncol Biol Phys
2022
36518323
Proton therapy for isolated local regional recurrence of breast cancer after mastectomy alone.
Front Oncol
2022
36896215
Initial Quality of Life and Toxicity Analysis of a Randomized Phase 3 Study of Moderately Hypofractionated Radiation Therapy With or Without Androgen Suppression for Intermediate-Risk Adenocarcinoma of the Prostate: PCG GU003.
Adv Radiat Oncol
2022
36093343
Outcomes and toxicities after proton partial breast radiotherapy for early stage, hormone receptor positive breast cancer: 3-Year results of a phase II multi-center trial.
Clin Transl Radiat Oncol
2022
35306151
Chemoradiation with Hypofractionated Proton Therapy in Stage II-III Non-Small Cell Lung Cancer: A Proton Collaborative Group Phase 2 Trial.
Int J Radiat Oncol Biol Phys
2022
34929404
Factors Associated With Acute Toxicity in Pediatric Patients Treated With Proton Radiation Therapy: A Report From the Pediatric Proton Consortium Registry.
Pract Radiat Oncol
2022
32866566
Risk of Pneumonitis and Outcomes After Mediastinal Proton Therapy for Relapsed/Refractory Lymphoma: A PTCOG and PCG Collaboration.
Int J Radiat Oncol Biol Phys
2021
33852456
Selection of Mediastinal Lymphoma Patients for Proton Therapy Within the Proton Collaborative Group Registry: Concordance With the ILROG Guidelines.
Am J Clin Oncol
2021
35071826
Clinical Outcomes After Proton Beam Therapy for Locally Advanced Non-Small Cell Lung Cancer: Analysis of a Multi-institutional Prospective Registry.
Adv Radiat Oncol
2021
34707999
Radiation Induced Cavernomas in the Treatment of Pediatric Medulloblastoma: Comparative Study Between Proton and Photon Radiation Therapy.
Front Oncol
2021
34646969
Dosimetry and Acute Toxicity Profile of Patients With Esophageal Cancer Treated With Proton Beam Radiation Therapy: Outcomes From the Proton Collaborative Group REG001-09 Trial.
Adv Radiat Oncol
2021
34524836
Radiation Oncology's Place in Payment Reform: ASTRO Advocates for a Place at the Table.
JCO Oncol Pract
2021
31600082
An open invitation to join the Pediatric Proton/Photon Consortium Registry to standardize data collection in pediatric radiation oncology.
Br J Radiol
2020
32028342
ACR-ASTRO Practice Parameter for the Performance of Proton Beam Radiation Therapy.
Am J Clin Oncol
2020
31805791
Minimal acute toxicity from proton beam therapy for major salivary gland cancer.
Acta Oncol
2020
33204857
Treatment interruptions affect biochemical failure rates in prostate cancer patients treated with proton beam therapy: Report from the multi-institutional proton collaborative group registry.
Clin Transl Radiat Oncol
2020
33148296
Hypofractionated proton beam radiotherapy in patients with unresectable liver tumors: multi-institutional prospective results from the Proton Collaborative Group.
Radiat Oncol
2020
32297453
Acute toxicities after proton beam therapy following breast-conserving surgery for breast cancer: Multi-institutional prospective PCG registry analysis.
Breast J
2020
32258443
Patient reported outcomes following proton pencil beam scanning vs. passive scatter/uniform scanning for localized prostate cancer: Secondary analysis of PCG 001-09.
Clin Transl Radiat Oncol
2020
32251754
Hypofractionated Proton Therapy with Concurrent Chemotherapy for Locally Advanced Non-Small Cell Lung Cancer: A Phase 1 Trial from the University of Florida and Proton Collaborative Group.
Int J Radiat Oncol Biol Phys
2020
30426667
Using the Patient-Reported Outcomes Measurement Information System (PROMIS) to measure symptom burden reported by patients with brain tumors.
Pediatr Blood Cancer
2019
31673662
A Multi-Institutional Experience of Proton Beam Therapy for Sinonasal Tumors.
Adv Radiat Oncol
2019
31650043
Proton beam therapy delivered using pencil beam scanning vs. passive scattering/uniform scanning for localized prostate cancer: Comparative toxicity analysis of PCG 001-09.
Clin Transl Radiat Oncol
2019
31338974
Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
Breast J
2019
30802618
Clinical Outcomes of Patients With Recurrent Lung Cancer Reirradiated With Proton Therapy on the Proton Collaborative Group and University of Florida Proton Therapy Institute Prospective Registry Studies.
Pract Radiat Oncol
2019
30997512
Improved neuropsychological outcomes following proton therapy relative to X-ray therapy for pediatric brain tumor patients.
Neuro Oncol
2019
30784340
Proton therapy for thymic malignancies: multi-institutional patterns-of-care and early clinical outcomes from the proton collaborative group and the university of Florida prospective registries.
Acta Oncol
2019
26523442
Hypofractionated Versus Standard Fractionated Proton-beam Therapy for Low-risk Prostate Cancer: Interim Results of a Randomized Trial PCG GU 002.
Am J Clin Oncol
2018
29881715
An Update From the Pediatric Proton Consortium Registry.
Front Oncol
2018
30202801
Initial toxicity, quality-of-life outcomes, and dosimetric impact in a randomized phase 3 trial of hypofractionated versus standard fractionated proton therapy for low-risk prostate cancer.
Adv Radiat Oncol
2018
30085163
Proton therapy patterns of care among pediatric and adult patients with CNS tumors.
Neuro Oncol
2018
29431867
Spatially fractionated (GRID) radiation therapy using proton pencil beam scanning (PBS): Feasibility study and clinical implementation.
Med Phys
2018
29034790
Minimal toxicity after proton beam therapy for prostate and pelvic nodal irradiation: results from the proton collaborative group REG001-09 trial.
Acta Oncol
2018
29303019
First report of proton beam therapy for breast angiosarcoma from the prospective PCG registry.
Acta Oncol
2018
29102263
Gender and age make no difference in the re-irradiation of painful bone metastases: A secondary analysis of the NCIC CTG SC.20 randomized trial.
Radiother Oncol
2018
29188483
Minimal clinically important differences in the EORTC QLQ-C30 and brief pain inventory in patients undergoing re-irradiation for painful bone metastases.
Qual Life Res
2018
27826034
Multi-Institutional Prospective Study of Reirradiation with Proton Beam Radiotherapy for Locoregionally Recurrent Non-Small Cell Lung Cancer.
J Thorac Oncol
2017
28457577
Proton beam radiotherapy as part of comprehensive regional nodal irradiation for locally advanced breast cancer.
Radiother Oncol
2017
28797854
Computerized Adaptive Testing in Pediatric Brain Tumor Clinics.
J Pain Symptom Manage
2017
27084652
Feasibility of Proton Beam Therapy for Ocular Melanoma Using a Novel 3D Treatment Planning Technique.
Int J Radiat Oncol Biol Phys
2016
26515411
Predictive model for survival in patients having repeat radiation treatment for painful bone metastases.
Radiother Oncol
2016
26399406
Revisiting classification of pain from bone metastases as mild, moderate, or severe based on correlation with function and quality of life.
Support Care Cancer
2016
27673869
Low Levels of Acute Toxicity Associated With Proton Therapy for Low-Grade Glioma: A Proton Collaborative Group Study.
Int J Radiat Oncol Biol Phys
2016
27601952
Image-guided hypofractionated proton beam therapy for low-risk prostate cancer: Analysis of quality of life and toxicity, PCG GU 002.
Rep Pract Oncol Radiother
2016
27598806
Consensus Report From the Stockholm Pediatric Proton Therapy Conference.
Int J Radiat Oncol Biol Phys
2016
27187113
Severe Radiation Necrosis Successfully Treated With Bevacizumab in an Infant with Low-Grade Glioma and Tumor-Associated Intractable Trigeminal Neuralgia.
Pediatr Blood Cancer
2016
1 - 50 of 104
Column Actions
Search
Recommended Authors
Andrew Warner
Western University and London Regional Cancer Program
Career Start Year
2013
Number of shared co-authors
2
Soumyajit Roy
Rush University Medical Center
Career Start Year
2013
Number of shared co-authors
4
Nicholas G Zaorsky
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year
2012
Number of shared co-authors
7
Joseph Sia
Peter MacCallum Cancer Centre, University of Melbourne
Career Start Year
2011
Number of shared co-authors
0
Bradley J Stish
Mayo Clinic
Career Start Year
2007
Number of shared co-authors
4
Rahul D Tendulkar
Taussig Cancer Institute, Cleveland Clinic
Career Start Year
2006
Number of shared co-authors
3
Daniel R Gomez
Memorial Sloan Kettering Cancer Center
Career Start Year
2005
Number of shared co-authors
1
Albert J Chang
University of California Los Angeles
Career Start Year
2003
Number of shared co-authors
5
Philip Wong
Princess Margaret Cancer Centre, University Health Network
Career Start Year
2002
Number of shared co-authors
3
Neha Vapiwala
Abramson Cancer Center, University of Pennsylvania
Career Start Year
2001
Number of shared co-authors
7
Zhigang Zhang
Memorial Sloan Kettering Cancer Center
Career Start Year
2001
Number of shared co-authors
1
David A Palma
University of Western Ontario
Career Start Year
2000
Number of shared co-authors
1
Chiaojung Jillian Tsai
Memorial Sloan Kettering Cancer Center
Career Start Year
2000
Number of shared co-authors
0
Austin N Kirschner
Vanderbilt University Medical Center
Career Start Year
2000
Number of shared co-authors
0
Drew Moghanaki
University of California Los Angeles
Career Start Year
2000
Number of shared co-authors
3
Chandana A Reddy
Cleveland Clinic
Career Start Year
2000
Number of shared co-authors
3
Steve E Braunstein
University of California san francisco
Career Start Year
1998
Number of shared co-authors
3
Christopher U Jones
Sutter Medical Center Sacramento
Career Start Year
1998
Number of shared co-authors
9
Anthony J Cmelak
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year
1997
Number of shared co-authors
0
Michael L Steinberg
University of California los angeles
Career Start Year
1996
Number of shared co-authors
6
Alan W Katz
University of Rochester
Career Start Year
1996
Number of shared co-authors
2
Glenn Bauman
Western University and London Regional Cancer Program
Career Start Year
1994
Number of shared co-authors
6
Theodore L DeWeese
Johns Hopkins University School of Medicine
Career Start Year
1991
Number of shared co-authors
4
Karin Dieckmann
Medical University of Vienna
Career Start Year
1991
Number of shared co-authors
1
Jeff M Michalski
Washington University School of Medicine
Career Start Year
1990
Number of shared co-authors
15
David Joseph
Sir Charles Gairdner Hospital
Career Start Year
1990
Number of shared co-authors
4
Robert L Foote
Mayo Clinic
Career Start Year
1988
Number of shared co-authors
4
Silvia C Formenti
Weill Cornell Medical College
Career Start Year
1986
Number of shared co-authors
2
Andrzej Niemierko
Massachusetts General Hospital
Career Start Year
1982
Number of shared co-authors
2
James W Denham
University of Newcastle
Career Start Year
1980
Number of shared co-authors
4
row(s) 1 - 30 of 30
Collaborators
Edward Chow
University of Toronto
Co-authored papers
14
William F Demas
Salem Regional Medical Center
Co-authored papers
11
Peter Hoskin
Mount Vernon Cancer Centre
Co-authored papers
11
Andre Konski
Chester County Hospital
Co-authored papers
10
Deborah W Bruner
Emory University, USA Winship Cancer Institute, USA School of Medicine
Co-authored papers
7
Charles W Scarantino
University of North Carolina
Co-authored papers
6
Michael Brundage
Cancer Centre of Southeastern Ontario
Co-authored papers
6
Sara L Gallotto
Massachusetts General Hospital/Harvard Medical School
Co-authored papers
5
John H Suh
Taussig Cancer Institute, Cleveland Clinic
Co-authored papers
5
Keyue Ding
Queen's University
Co-authored papers
4
Robert Ivker
Prostate Cancer Center of New Jersey.
Co-authored papers
4
Mack Roach
University of California San Francisco
Co-authored papers
4
Stewart Goldman
Co-authored papers
4
Jennifer James
Institute on Health and Aging, University of California san francisco
Co-authored papers
4
Ivy A Petersen
Mayo Clinic
Co-authored papers
4
Jason Fangusaro
Co-authored papers
3
Andrea M Barsevick
Thomas Jefferson University
Co-authored papers
2
Helen A Shih
Massachusetts General Hospital and Harvard Medical School
Co-authored papers
2
Peter E Manley
Co-authored papers
2
Rishi R Lulla
Hasbro Children's Hospital, Brown University.
Co-authored papers
2
Sarah J Ratcliffe (CM4AI)
University of Virginia
Co-authored papers
2
Amar Gajjar
St. Jude Children's Research Hospital
Co-authored papers
1
Henry Mandeville
Co-authored papers
1
Minesh P Mehta
Co-authored papers
1
Howard M Sandler
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers
1
Michael A Golafshar
Mayo Clinic
Co-authored papers
1
Seth A Rosenthal
Sutter Cancer Centers Radiation Oncology Services
Co-authored papers
1
Tadanori Tomita
Co-authored papers
1
Reginald F Munden
Co-authored papers
1
Mark W Youngblood
Co-authored papers
1
1 - 30